Is SBTX undervalued or overvalued?

As of 2025-03-16, the Intrinsic Value of Silverback Therapeutics Inc (SBTX) is - USD. This SBTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.87 USD, the upside of Silverback Therapeutics Inc is -100.00%. This means that SBTX is overvalued by 100.00%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	- - -	-	-100.00%
P/E	(30.12) - (46.09)	(36.41)	-720.2%
DDM - Stable	(6.36) - (21.75)	(14.05)	-339.4%
DDM - Multi	(3.07) - (8.67)	(4.59)	-178.2%